PMP22 and Charcot-Marie-Tooth disease type 1A: Transgenic overexpression of Pmp22 also induces dys- and demyelination and, in this case, a slowly progressive, distally pronounced, axonal loss (Sereda et al., 1996; Fledrich et al., 2014), providing a bona fide model of human Charcot-Marie-Tooth disease type 1A (CMT1A).